Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
NCT00250068
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Lung Diseases
Cancer
Interventions
DRUG:
Liposomal 9-Nitrocamptothecin
Sponsor
University of New Mexico